Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Tomaschitz

Showing results (71-80 of 135) with videos related to

Pageof 14
Sort By:
Scientific Reports|July 7, 2017
Refining Long-Term Prediction of Cardiovascular Risk in Diabetes - The VILDIA ScoreGeorg Goliasch, Günther Silbernagel, Marcus E Kleber, et al.
European Heart Journal|August 23, 2011
Serum aldosterone and its relationship to left ventricular structure and geometry in patients with preserved left ventricular ejection fractionFrank Edelmann, Andreas Tomaschitz, Rolf Wachter, et al.
Atherosclerosis|May 28, 2013
Cystatin C is independently associated with total and cardiovascular mortality in individuals undergoing coronary angiography. The Ludwigshafen Risk and Cardiovascular Health (LURIC) studyRainer P Woitas, Marcus E Kleber, Andreas Meinitzer, et al.
Swiss Medical Weekly|December 16, 2018
Association of allostatic load with health-related quality of life in patients with arterial hypertension: a cross-sectional analysisFranziska Matzer, Christian Fazekas, Christian Vajda, et al.
European Heart Journal|December 6, 2012
Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patientsChristiane Drechsler, Eberhard Ritz, Andreas Tomaschitz, et al.
BMC Endocrine Disorders|April 9, 2009
Graz Endocrine Causes of Hypertension (GECOH) study: a diagnostic accuracy study of aldosterone to active renin ratio in screening for primary aldosteronismStefan Pilz, Andreas Tomaschitz, Vinzenz Stepan, et al.
Atherosclerosis|September 10, 2014
Fibroblast growth factor 23 (FGF23) and mortality: the Ludwigshafen Risk and Cardiovascular Health StudyVincent M Brandenburg, Marcus E Kleber, Marc G Vervloet, et al.
Circulation. Heart Failure|October 25, 2014
Von Willebrand factor improves risk prediction in addition to N-terminal pro-B-type natriuretic peptide in patients referred to coronary angiography and signs and symptoms of heart failure and preserved ejection fractionMarcus E Kleber, Lorenz Koller, Georg Goliasch, et al.
Calcified Tissue International|March 25, 2009
25-hydroxyvitamin D is not associated with carotid intima-media thickness in older men and womenStefan Pilz, Ronald M A Henry, Marieke B Snijder, et al.
ESC Heart Failure|February 21, 2019
Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fractionKathleen Nolte, Christoph Herrmann-Lingen, Lars Platschek, et al.
Pageof 14

Showing results (71-80 of 135) with videos related to

Sort By:
Pageof 14
Scientific Reports|July 7, 2017
Refining Long-Term Prediction of Cardiovascular Risk in Diabetes - The VILDIA ScoreGeorg Goliasch, Günther Silbernagel, Marcus E Kleber, et al.
European Heart Journal|August 23, 2011
Serum aldosterone and its relationship to left ventricular structure and geometry in patients with preserved left ventricular ejection fractionFrank Edelmann, Andreas Tomaschitz, Rolf Wachter, et al.
Atherosclerosis|May 28, 2013
Cystatin C is independently associated with total and cardiovascular mortality in individuals undergoing coronary angiography. The Ludwigshafen Risk and Cardiovascular Health (LURIC) studyRainer P Woitas, Marcus E Kleber, Andreas Meinitzer, et al.
Swiss Medical Weekly|December 16, 2018
Association of allostatic load with health-related quality of life in patients with arterial hypertension: a cross-sectional analysisFranziska Matzer, Christian Fazekas, Christian Vajda, et al.
European Heart Journal|December 6, 2012
Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patientsChristiane Drechsler, Eberhard Ritz, Andreas Tomaschitz, et al.
BMC Endocrine Disorders|April 9, 2009
Graz Endocrine Causes of Hypertension (GECOH) study: a diagnostic accuracy study of aldosterone to active renin ratio in screening for primary aldosteronismStefan Pilz, Andreas Tomaschitz, Vinzenz Stepan, et al.
Atherosclerosis|September 10, 2014
Fibroblast growth factor 23 (FGF23) and mortality: the Ludwigshafen Risk and Cardiovascular Health StudyVincent M Brandenburg, Marcus E Kleber, Marc G Vervloet, et al.
Circulation. Heart Failure|October 25, 2014
Von Willebrand factor improves risk prediction in addition to N-terminal pro-B-type natriuretic peptide in patients referred to coronary angiography and signs and symptoms of heart failure and preserved ejection fractionMarcus E Kleber, Lorenz Koller, Georg Goliasch, et al.
Calcified Tissue International|March 25, 2009
25-hydroxyvitamin D is not associated with carotid intima-media thickness in older men and womenStefan Pilz, Ronald M A Henry, Marieke B Snijder, et al.
ESC Heart Failure|February 21, 2019
Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fractionKathleen Nolte, Christoph Herrmann-Lingen, Lars Platschek, et al.
Pageof 14